Bristol Myers Squibb (BMYMP) FCF Margin (2016 - 2025)
Bristol Myers Squibb (BMYMP) has disclosed FCF Margin for 17 consecutive years, with 12.83% as the latest value for Q4 2025.
- Quarterly FCF Margin fell 2007.0% to 12.83% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 26.65% through Dec 2025, down 221.0% year-over-year, with the annual reading at 26.65% for FY2025, 221.0% down from the prior year.
- FCF Margin for Q4 2025 was 12.83% at Bristol Myers Squibb, down from 49.02% in the prior quarter.
- The five-year high for FCF Margin was 49.02% in Q3 2025, with the low at 12.83% in Q4 2025.
- Average FCF Margin over 5 years is 28.48%, with a median of 29.77% recorded in 2022.
- The sharpest move saw FCF Margin surged 2292bps in 2021, then plummeted -2007bps in 2025.
- Over 5 years, FCF Margin stood at 31.18% in 2021, then dropped by -17bps to 25.95% in 2022, then skyrocketed by 32bps to 34.17% in 2023, then dropped by -4bps to 32.9% in 2024, then tumbled by -61bps to 12.83% in 2025.
- According to Business Quant data, FCF Margin over the past three periods came in at 12.83%, 49.02%, and 28.98% for Q4 2025, Q3 2025, and Q2 2025 respectively.